Original Research

Real-world experience of everolimus as second-line treatment in metastatic renal cell cancer after failure of pazopanib

Koutsoukos K, Bamias A, Tzannis K, Espinosa Montaño M, Bozionelou V, Christodoulou C, Stefanou D, Kalofonos H, Duran I, Papazisis K

OncoTargets and Therapy 2017, 10:4885-4893

Published Date: 6 October 2017